-
How J&J Kept Growing Amid the Erosion of Cornerstone Drug Stelara
22 Oct 2025 04:36 GMT
… on a drug that accounted for 20% of innovative medicine sales in … ;J still grew global innovative medicine revenue by 5%.
BioSpace, … despite sales of Concerta and Invega falling. Spravato is the … J’s third biggest innovative medicine unit after oncology and …
-
No Trump Drug Pricing Plan For J&J—Yet
14 Oct 2025 14:59 GMT
… a Most Favored Nation drug pricing deal. Pfizer and … Spravato and more.
The pharmaceuticals segment produced $15.6 … schizophrenia and bipolar disorder medicine acquired via the $14 … particularly strong, while antipsychotic Invega and prostate cancer med …
-
Supreme Court of Canada reserves decision on appeal relating to the patentability of methods of medical treatment
11 Oct 2025 01:05 GMT
… (INVEGA SUSTENNA) is invalid for claiming an unpatentable method of medical treatment … a drug or treatment is to be administered by a medical practitioner … from intervenors, the Canadian Generic Pharmaceutical Association (CGPA), Fédération Internationale …
-
New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-'749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed
21 Sep 2025 02:15 GMT
… prescribed daily oral medicines for the treatment of schizophrenia. … experiencing TEAEs leading to trial discontinuation. Serious AEs were … 1 Invega Sustenna® is a product of Janssen Pharmaceuticals, Inc … Adverse Reactions: In trials of elderly patients …
-
Teva preesents 10 posters from its schizophrenia medicines portfolio
21 Sep 2025 22:11 GMT
… Pharmaceutical Industries, announced the presentation of 10 posters from its schizophrenia medicines … SOLARIS Phase 3 trial showing no incidence … months for the treatment of schizophrenia in adults … intramuscular injection of Invega Sustenna. No comparisons …
-
Nanocrystalline Drug Delivery Systems for Natural Compounds: Progress, Challenges and Future Opportunities
17 Sep 2025 17:46 GMT
… remedies in the realm of drug development.6
Despite their considerable medicinal … products: a review. Biotechnol Adv. 2015;33( … for the treatment of bronchopulmonary aspergillosis. … polysaccharide nanocrystals as pharmaceutical excipients. Carbohydr Polym. …
-
Controlled Release Drug Delivery Market And Clinical Pipeline Report: A $90 Billion Opportunity In Controlled Release Drug Delivery By 2030
26 Aug 2025 09:28 GMT
… Release Drugs In Clinical Trials: > 190 Drugs Global … drug absorption, frequently undermine treatment efficacy. Controlled drug … Drug Release Systems A number of major pharmaceutical and biotech … Invega (Extended-Release)
10.2 Invega Franchise/Invega …
-
Allentown pharmacy to pay feds $825,000 to resolve false Medicare billing allegations
09 Aug 2025 02:00 GMT
… West End Services billed Medicare for prescription drugs that were not … actually dispensed to Medicare beneficiaries between … late February 2019.
Medications included Latuda, Humira, Abilify, Invega Sustenna, Seroquel, …
-
Local pharmacy to pay $825K over false Medicare claims, U.S. Attorney says
08 Aug 2025 17:43 GMT
… 24, 2019, WES billed Medicare for prescription drugs that were not actually … dispensed to Medicare beneficiaries, the U … these medications included, but were not limited to, Latuda, Humira, Abilify, Invega …
-
Optum Rx Eliminates Reauthorization on an Additional 60 Drugs
30 Jun 2025 21:20 GMT
… drugs that treat chronic conditions. The newly added medications include treatments … capsules, Eprontia, Elepsia XR
• Antidepressants: Aplenzin, Forfivo XL, Bupropion … Lybalvi, Opipza, Saphris, Secuado, Invega Hafyera
• Antihypertensives: Kapspargo, Edarbi, …